Establish Novartis as the House of Dermatology and Immunology
RCT
AS
JPsA
EA
IV
PsA/AS
LN
GCA
PsA
nr-axSpA
Redefining leadership through new indications in Rheumatology
2023
2026
2024
2025
2020
2022
2015
PsO
Lichen
Plan
Atopic Dermatitis
Smart pack
Ped Pso
HS
PsA
Leading Skin diseases Management Transformation
2023
2026
2024
2025
2020
2022
2015
CSU
NP
FA
SAA
Cosentyx PsO
Strategic focus
Market Overview
Key Achievement
Tactics
Market Overview
50 million USD
PSO Market Size
80% for IL17s and IL23s
Efficacy, access and engagement driven market with full fledge competition
Key Achievement
Key Achievement
Market leader in PsO
Since 2017
Despite fierce competition
Strategic focus
Strategic focus
Defend Cosentyx as 1st line Bx in PsO
Differentiation in Skin clearance and Complete treatment
Enhance customer experience and loyalty
Through seamless patient access programs
Empower patients
Patient education and activation campaigns to shorten the time for optimal treatment
Tactics
Tactics
leave no Stakeholder Behind
Cosentyx PsA
Strategic focus
Market Overview
Key Achievement
Tactics
Market Overview
12.5 million USD
PsA Market Size
50% for IL17s
Crowded efficacy & Safety driven Market , sensitive to patient's services as Rheumatologists seek smooth treatment option
Key Achievement
Key Achievement
Market leader in PsAA
Since 2017
Despite fierce competition
Strategic focus
Strategic focus
Differentiation within Class
Pre-positioning of new Entrants
Operational Excellence
Rheuma- Derma collaboration
Tactics
Cosentyx
gehad hemidah
Created on November 19, 2021
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Randomizer
View
Timer
View
Find the pair
View
Hangman Game
View
Dice
View
Scratch and Win Game
View
Create a Word Search
Explore all templates
Transcript
Establish Novartis as the House of Dermatology and Immunology
RCT
AS
JPsA EA
IV PsA/AS
LN
GCA
PsA
nr-axSpA
Redefining leadership through new indications in Rheumatology
2023
2026
2024
2025
2020
2022
2015
PsO
Lichen Plan
Atopic Dermatitis
Smart pack
Ped Pso
HS
PsA
Leading Skin diseases Management Transformation
2023
2026
2024
2025
2020
2022
2015
CSU
NP
FA
SAA
Cosentyx PsO
Strategic focus
Market Overview
Key Achievement
Tactics
Market Overview
50 million USD
PSO Market Size
80% for IL17s and IL23s
Efficacy, access and engagement driven market with full fledge competition
Key Achievement
Key Achievement
Market leader in PsO
Since 2017
Despite fierce competition
Strategic focus
Strategic focus
Defend Cosentyx as 1st line Bx in PsO
Differentiation in Skin clearance and Complete treatment
Enhance customer experience and loyalty
Through seamless patient access programs
Empower patients
Patient education and activation campaigns to shorten the time for optimal treatment
Tactics
Tactics
leave no Stakeholder Behind
Cosentyx PsA
Strategic focus
Market Overview
Key Achievement
Tactics
Market Overview
12.5 million USD
PsA Market Size
50% for IL17s
Crowded efficacy & Safety driven Market , sensitive to patient's services as Rheumatologists seek smooth treatment option
Key Achievement
Key Achievement
Market leader in PsAA
Since 2017
Despite fierce competition
Strategic focus
Strategic focus
Differentiation within Class
Pre-positioning of new Entrants
Operational Excellence
Rheuma- Derma collaboration
Tactics